Shahnoz Rustamova
Obstetrics · New York, NYNPI 1629112149
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $894 and has fallen 59.2% since, to $365 in 2025. Among obstetrics clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $16.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$752
- Avion Pharmaceuticals$488
- Evofem Biosciences, Inc.$470
- Mayne Pharma Commercial LLC$312
- Therapeuticsmd, Inc.$216
- Exeltis, USA Inc.$167
- plus $1K from 17 others
What the payments were for
- Food & beverage$3,68198%
- Education$622%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $752 |
| Avion Pharmaceuticals | 31 | $488 |
| Evofem Biosciences, Inc. | 26 | $470 |
| Mayne Pharma Commercial LLC | 19 | $312 |
| Therapeuticsmd, Inc. | 14 | $216 |
| Exeltis, USA Inc. | 18 | $167 |
| Millicent US Inc | 8 | $160 |
| Coopersurgical, Inc. | 8 | $142 |
| Zyla Life Sciences, Inc. | 7 | $113 |
| Pfizer | 6 | $112 |
| Myovant Sciences Inc. | 5 | $108 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Scynexis, Inc. | 5 | $87 |
| Merck | 5 | $83 |
| Shield Therapeutics Inc | 3 | $70 |
| Organon | 3 | $64 |
| Biogen | 3 | $64 |
| Agile Therapeutics, Inc. | 4 | $54 |
| Vertical Pharmaceuticals, LLC | 3 | $53 |
| Novum Pharma, LLC | 3 | $48 |
| AMAG Pharmaceuticals, Inc. | 3 | $45 |
| Astellas Pharma US Inc | 1 | $32 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$3,743 in reported general payments places this provider in the 95th percentile of 82 obstetrics providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 39 | $3,464 |
| ValacyclovirValacyclovir Hcl | 30 | $1,524 |
| Estradiol (Once Weekly)Estradiol | 11 | $461 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in New York
- Anna BarbieriNew York$9K
- Suzanne LajoieNew York$3K
- Mary Cathryn EarnhardtNew York$1K
- Alison HoNew York$1K
- Sara SlatkyNew York$1K
- Lorraine ChrisomalisNew York$777
- Hope LangerNew York$772
- Gary MarkoffNew York$625
- Elena BuruianaNew York$601
- Bruno CaridiNew York$343
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.